(secondQuint)T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA.

 This research study is a Phase II clinical trial.

 Phase II clinical trials test the safety and effectiveness of an investigational intervention to learn whether the intervention works in treating a specific disease.

 "Investigational" means that the intervention is being studied.

 The FDA (the U.

S.

 Food and Drug Administration) has not approved T-DM1 for pre-operative use in breast cancer but it has been approved for other uses in breast cancer.

 The FDA has approved pertuzumab as a pre-operative treatment.

.

 T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA@highlight

This research study is studying a combination of drugs as a possible treatment for breast cancer that has tested positive for a protein called HER2.

 The names of the study interventions involved in this study are: - Trastuzumab emtansine (also called T-DM1) - Pertuzumab